Good afternoon :)
Place Order
Add to Watchlist

Ajooni Biotech Ltd

AJOONI Share Price

5.840.85% (-0.05)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹101 cr, stock is ranked 2,995

High Risk

Stock is 3.32x as volatile as Nifty

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹101 cr, stock is ranked 2,995

High Risk

Stock is 3.32x as volatile as Nifty

AJOONI Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
30.372.38—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.416.500.86%

AJOONI Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AJOONI Company Profile

Ajooni Biotech Pvt Ltd is a manufacturer of medicinals and botanicals

AJOONI Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.76
1Y Return
15.25%
Buy Reco %
87.88
Cipla Ltd
CIPLA
PE Ratio
22.52
1Y Return
1.23%
Buy Reco %
74.19
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
55.39
1Y Return
18.55%
Buy Reco %
72.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.36
1Y Return
7.87%
Buy Reco %
53.33
Mankind Pharma Ltd
MANKIND
PE Ratio
50.04
1Y Return
13.59%
Buy Reco %
81.25
Compare with Peers

AJOONI Forecasts

AJOONI Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AJOONI

Income

Balance Sheet

Cash Flow

AJOONI Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.49%, vs industry avg of 9.04%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.02%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 39.29%, vs industry avg of 15.28%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue28.5842.5940.0640.0951.0674.0874.7882.30116.76116.76
Raw Materialssubtract24.4237.5536.4634.9443.3663.9166.1269.86111.00111.02
Power & Fuel Costsubtract0.000.300.570.621.050.920.690.82
Employee Costsubtract0.590.880.721.121.151.481.761.80
Selling & Administrative Expensessubtract0.002.221.121.913.743.512.913.96
Operating & Other expensessubtract2.860.490.160.210.101.140.241.44
Depreciation/Amortizationsubtract0.190.310.440.490.581.111.000.871.091.07
Interest & Other Itemssubtract0.140.350.110.330.580.540.480.560.330.34
Taxes & Other Itemssubtract0.110.100.070.140.130.410.450.840.950.99
EPS0.100.030.020.010.010.050.140.220.200.34
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

AJOONI Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual Report Pending

Investor Presentation

Jun 29PDF
 

AJOONI Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Ajooni Biotech Ltd29.932.38—
Sun Pharmaceutical Industries Ltd36.765.990.96%
Cipla Ltd22.524.431.09%
Torrent Pharmaceuticals Ltd55.3915.441.02%

AJOONI Stock Price Comparison

Compare AJOONI with any stock or ETF
Compare AJOONI with any stock or ETF
AJOONI
Loading...

AJOONI Shareholdings

AJOONI Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AJOONI Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AJOONI Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding26.89%0.00%0.00%0.00%73.11%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

AJOONI Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.29%0.18%0.00%

AJOONI Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AJOONI stock

Looks like this stock is not in any smallcase yet.

AJOONI Events

AJOONI Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AJOONI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

AJOONI Dividends

Hmm, looks like data is unavailable here. Please come back after some time

AJOONI Stock News & Opinions

Earnings
Ajooni Biotech standalone net profit rises 69.23% in the March 2025 quarter

Net profit of Ajooni Biotech rose 69.23% to Rs 1.54 crore in the quarter ended March 2025 as against Rs 0.91 crore during the previous quarter ended March 2024. Sales rose 49.49% to Rs 29.27 crore in the quarter ended March 2025 as against Rs 19.58 crore during the previous quarter ended March 2024. For the full year,net profit rose 56.02% to Rs 3.37 crore in the year ended March 2025 as against Rs 2.16 crore during the previous year ended March 2024. Sales rose 43.17% to Rs 114.69 crore in the year ended March 2025 as against Rs 80.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales29.2719.58 49 114.6980.11 43 OPM %3.458.07 -3.202.80 - PBDT2.291.73 32 5.413.87 40 PBT1.911.49 28 4.323.00 44 NP1.540.91 69 3.372.16 56 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Ajooni Biotech announces board meeting date

Ajooni Biotech will hold a meeting of the Board of Directors of the Company on 26 May 2025.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Ajooni Biotech standalone net profit rises 65.91% in the December 2024 quarter

Net profit of Ajooni Biotech rose 65.91% to Rs 0.73 crore in the quarter ended December 2024 as against Rs 0.44 crore during the previous quarter ended December 2023. Sales rose 69.73% to Rs 34.03 crore in the quarter ended December 2024 as against Rs 20.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales34.0320.05 70 OPM %2.73-3.29 - PBDT1.250.79 58 PBT1.010.58 74 NP0.730.44 66 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ajooni Biotech to table results

Ajooni Biotech will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ajooni Biotech schedules EGM

Ajooni Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Ajooni Biotech to consider Fund Raising

Ajooni Biotech will hold a meeting of the Board of Directors of the Company on 31 December 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Ajooni Biotech standalone net profit rises 55.00% in the September 2024 quarter

Net profit of Ajooni Biotech rose 55.00% to Rs 0.62 crore in the quarter ended September 2024 as against Rs 0.40 crore during the previous quarter ended September 2023. Sales rose 32.03% to Rs 25.72 crore in the quarter ended September 2024 as against Rs 19.48 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales25.7219.48 32 OPM %3.033.23 - PBDT1.030.73 41 PBT0.800.52 54 NP0.620.40 55 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Ajooni Biotech declare Quarterly Result

Ajooni Biotech will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Ajooni Biotech AGM scheduled

Ajooni Biotech announced that the 14th Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Ajooni Biotech to conduct board meeting

Ajooni Biotech will hold a meeting of the Board of Directors of the Company on 16 August 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Ajooni Biotech Ltd (AJOONI) today?

    The share price of AJOONI as on 3rd June 2025 is ₹5.84. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Ajooni Biotech Ltd (AJOONI) share?

    The past returns of Ajooni Biotech Ltd (AJOONI) share are
    • Past 1 week: -1.01%
    • Past 1 month: -1.84%
    • Past 3 months: -20.19%
    • Past 6 months: -25.82%
    • Past 1 year: -2.64%
    • Past 3 years: -30.05%
    • Past 5 years: -12.67%

  3. What are the peers or stocks similar to Ajooni Biotech Ltd (AJOONI)?

    The peers or stocks similar to Ajooni Biotech Ltd (AJOONI) include:

  4. What is the market cap of Ajooni Biotech Ltd (AJOONI) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ajooni Biotech Ltd (AJOONI) is ₹101.45 Cr as of 3rd June 2025.

  5. What is the 52 week high and low of Ajooni Biotech Ltd (AJOONI) share?

    The 52-week high of Ajooni Biotech Ltd (AJOONI) is ₹10.34 and the 52-week low is ₹4.95.

  6. What is the PE and PB ratio of Ajooni Biotech Ltd (AJOONI) stock?

    The P/E (price-to-earnings) ratio of Ajooni Biotech Ltd (AJOONI) is 29.93. The P/B (price-to-book) ratio is 2.38.

  7. Which sector does Ajooni Biotech Ltd (AJOONI) belong to?

    Ajooni Biotech Ltd (AJOONI) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Ajooni Biotech Ltd (AJOONI) shares?

    You can directly buy Ajooni Biotech Ltd (AJOONI) shares on Tickertape. Simply sign up, connect your demat account and place your order.